MorphoSys AG (MOR)

MorphoSys AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	238.28	278.27	179.61	327.7	71.76
Revenue Growth (YoY)	-14.37%	54.93%	-45.19%	356.69%	-6.13%
Cost of Revenue	58.35	48.62	32.19	9.17	12.09
Gross Profit	179.92	229.65	147.42	318.52	59.67
Selling, General & Admin	147.17	152.55	199.83	159.15	59.34
Research & Development	283.61	297.81	225.21	139.37	108.43
Other Operating Expenses	1.62	0	230.71	2.06	0
Operating Expenses	432.4	450.36	655.76	300.57	167.77
Operating Income	-252.48	-220.71	-508.34	17.95	-108.1
Interest Expense / Income	141.98	165.9	181.46	96.21	2.27
Other Expense / Income	-203.53	-404.13	-98.75	-100.75	-3.85
Pretax Income	-190.92	17.52	-591.05	22.49	-106.52
Income Tax	-1.19	168.58	-76.59	-75.4	-3.51
Net Income	-189.73	-151.06	-514.46	97.89	-103.01
Shares Outstanding (Basic)	34	34	33	33	32
Shares Outstanding (Diluted)	34	34	33	33	32
Shares Change	0.46%	2.26%	0.70%	4.92%	0.87%
EPS (Basic)	-1.38	-1.10	-3.85	-	-0.81
EPS (Diluted)	-1.38	-1.10	-3.85	-	-0.81
Free Cash Flow	-296.19	-368.64	-485.26	30.81	-84.15
Free Cash Flow Per Share	-2.16	-2.70	-3.63	0.24	-0.67
Gross Margin	75.51%	82.53%	82.08%	97.20%	83.16%
Operating Margin	-105.96%	-79.32%	-283.02%	5.48%	-150.65%
Profit Margin	-79.63%	-54.29%	-286.43%	29.87%	-143.56%
Free Cash Flow Margin	-124.30%	-132.48%	-270.17%	9.40%	-117.28%
Effective Tax Rate	-	962.19%	-	-335.22%	-
EBITDA	-38.41	193.95	-399.5	127.04	-98
EBITDA Margin	-16.12%	69.70%	-222.43%	38.77%	-136.58%
Depreciation & Amortization	10.54	10.54	10.09	8.33	6.25
EBIT	-48.94	183.42	-409.59	118.71	-104.25
EBIT Margin	-20.54%	65.91%	-228.04%	36.22%	-145.28%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).